HIGHLIGHTS
- who: Daniel Samarai from the (UNIVERSITY) have published the Article: Novel oral anticoagulant use in adults with congenital heart disease: a single-center experience report, in the Journal: (JOURNAL)
- what: The study showed a low prevalence of both thrombotic and bleeding events in the rivaroxaban and the acetylsalicylic acid groups.
- how: The study consists of a small heterogeneous ACHD population and short followup.
SUMMARY
Treatment. In the recently published study in ACHD patients the authors observed an average VKA treatment of good quality with a high TTR and low . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.